Daewoong Pharmaceutical, sole sales operation of Sandoz osteoporosis treatment, Sandoz Soledronic Acid Inj, to hospitals and clinics

Published: 2014-09-22 10:53:14

Updated: 2014-09-22 10:53:14

Daewoong Pharmaceutical has signed a strategic cooperation contract of ‘Sandoz Zoledronic Acid Inj.’, which is an osteoporosis treatment that is administered once a year, with Sandoz Korea and started to sell.

With the contract, Daewoong Pharmaceutical will start their business activity of Sandoz Zoledronic acid Inj. to nationwide hospitals and clinics from September.

Jongwook Lee, who is the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.